Previous studies have demonstrated that EBV-infected GC patients have been reported to react to anti-PD-1/L1 antibodies, in spite of the lower MSI or TMB (Kim et al., 2018; Panda et al., 2018). Here, PDCD1 is linked to gastric cancer.